[1]
|
A. Jemal, T. Murray, E. Ward, et al., “Cancer Statistics, 2005,” CA—A Cancer Journal for Clinicians, Vol. 55, No. 1, 2005, pp. 10-30. doi:10.3322/canjclin.55.1.10
|
[2]
|
E. L. Wynder and E. A. Graham, “Landmark Article May 27, 1950: Tobacco Smoking as a Possible Etiologic Factor in Bronchiogenic Carcinoma. A Study of Six Hundred and Eighty-Four Proved Cases,” JAMA, Vol. 253, No. 20, 1985, pp. 2986-2994.
doi:10.1001/jama.1985.03350440064033
|
[3]
|
D. M. Parkin, F. Bray, J. Ferlay and P. Pisani, “Global Cancer Statistics, 2002,” CA—A Cancer Journal for Clinicians, Vol. 55, No. 2, 2005, pp. 74-108.
doi:10.3322/canjclin.55.2.74
|
[4]
|
R. Gealy, L. Zhang, J. M. Siegfried, J. D. Luketich and P. Keohavong, “Comparison of Mutations in the p53 and K-Ras Genes in Lung Carcinomas from Smoking and Nonsmoking Women,” Cancer Epidemiology, Biomarkers & Prevention, Vol. 8, No. 4, 1999, pp. 297-302.
|
[5]
|
S. Sun, J. H. Schiller and A. F. Gazdar, “Lung Cancer in Never Smokers—A Different Disease,” Nature Reviews Cancer, Vol. 7, 2007, pp. 778-790. doi:10.1038/nrc2190
|
[6]
|
C. K. Toh, F. Gao, W. T. Lim, et al., “Never-Smokers with Lung Cancer: Epidemiologic Evidence of a Distinct Disease Entity,” Journal of Clinical Oncology, Vol. 24, No. 34, 2006, pp. 2245-2251.
doi:10.1200/JCO.2005.04.8033
|
[7]
|
C. M. Tammemagi, C. Neslund-Dudas, M. Simoff and P. Kvale, “Smoking and Lung Cancer Survival: The Role of Comorbidity and Treatment,” Chest, Vol. 125, No. 1, 2004, pp. 27-37. doi:10.1378/chest.125.1.27
|
[8]
|
A. S. Tsao, D. Liu, J. J. Lee, M. Spitz and W. K. Hong, “Smoking Affects Treatment Outcome in Patients with Advanced Nonsmall Cell Lung Cancer,” Cancer, Vol. 106, No. 11, 2006, pp. 2428-2436.
doi:10.1002/cncr.21884
|
[9]
|
T. J. Lynch, D. W. Bell, R. Sordella, et al., “Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non-Small-Cell Lung Cancer to Gefitinib,” New England Journal of Medicine, Vol. 350, No. 21, 2004, pp. 2129-2139.
doi:10.1056/NEJMoa040938
|
[10]
|
S. W. Han, T. Y. Kim, P. G. Hwang, et al., “Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non-Small-Cell Lung Cancer Patients Treated with Gefitinib,” Journal of Clinical Oncology, Vol. 23, No. 16, 2005, pp. 2493-2501.
doi:10.1200/JCO.2005.01.388
|
[11]
|
S. N. Rodin and A. S. Rodin, “On the Excess of G --> T Transversions in the p53 Gene in Lung Cancer Cell Lines. Reply to Pfeifer and Hainaut,” Mutation Research, Vol. 545, No. 1-2, 2004, pp. 141-147.
doi:10.1016/j.mrfmmm.2003.09.008
|
[12]
|
C. K. Toh, E. H. Wong, W. T. Lim, et al., “The Impact of Smoking Status on the Behavior and Survival Outcome of Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Analysis,” Chest, Vol. 126, No. 6, 2004, pp. 1750-1756. doi:10.1378/chest.126.6.1750
|
[13]
|
J. Subramanian and R. Govindan, “Lung Cancer in Never Smokers: A Review,” Journal of Clinical Oncology, Vol. 25, No. 5, 2007, pp. 561-570.
doi:10.1200/JCO.2006.06.8015
|
[14]
|
G. Selvaggi and G. V. Scagliotti, “Histologic Subtype in NSCLC: Does It Matter?” Oncology, Vol. 23, No. 13, 2009, pp. 1133-1140.
|
[15]
|
T. Kawaguchi, A. Matsumura, S. Fukai, et al., “Japanese Ethnicity Compared with Caucasian Ethnicity and Never-Smoking Status Are Independent Favorable Prognostic Factors for Overall Survival in Non-small Cell Lung Cancer: A Collaborative Epidemiologic Study of the National Hospital Organization Study Group for Lung Cancer (NHSGLC) in Japan and a Southern California Regional Cancer Registry Databases,” Journal of Thoracic Oncology, Vol. 5, No. 7, 2010, pp. 1001-1010.
|
[16]
|
L. A. Loeb, V. L. Ernster, K. E. Warner, J. Abbotts and J. Laszlo, “Smoking and Lung Cancer: An Overview,” Cancer Research, Vol. 44, No. 12, 1984, pp. 5940-5958.
|
[17]
|
H. A. Wakelee, E. T. Chang, S. L. Gomez, et al., “Lung Cancer Incidence in Never Smokers,” Journal of Clinical Oncology, Vol. 25, No. 5, 2007, pp. 472-478.
doi:10.1200/JCO.2006.07.2983
|
[18]
|
L. C. Koo and J. H. Ho, “Worldwide Epidemiological Patterns of Lung Cancer in Nonsmokers,” International Journal of Epidemiology, Vol. 19, Suppl. 1, 1990, pp. S14-S23.
|
[19]
|
L. S. Wistuba II, C. Behrens, et al., “Molecular Damage in the Bronchial Epithelium of Current and Former Smokers,” Journal of the National Cancer Institute, Vol. 89, No. 18, 1997, pp. 1366-1373.
doi:10.1093/jnci/89.18.1366
|
[20]
|
L. Mao, J. S. Lee, J. M. Kurie, et al., “Clonal Genetic Alterations in the Lungs of Current and Former Smokers,” Journal of the National Cancer Institute, Vol. 89, No. 12, 1997, pp. 857-862. doi:10.1093/jnci/89.12.857
|
[21]
|
D. Pham, M. G. Kris, G. J. Riely, et al., “Use of Cigarette-Smoking History to Estimate the Likelihood of Mutations in Epidermal Growth Factor Receptor Gene Exons 19 and 21 in Lung Adenocarcinomas,” Journal of Clinical Oncology, Vol. 24, 2006, pp. 1700-1704.
doi:10.1200/JCO.2005.04.3224
|
[22]
|
C. A. Powell, A. Spira, A. Derti, et al., “Gene Expression in Lung Adenocarcinomas of Smokers and Nonsmokers,” American Journal of Respiratory Cell and Molecular Biology, Vol. 29, No. 2, 2003, pp. 157-162.
doi:10.1165/rcmb.2002-0183RC
|
[23]
|
L. T. Nordquist, G. R. Simon, A. Cantor, W. M. Alberts and G. Bepler, “Improved Survival in Never-Smokers vs Current Smokers with Primary Adenocarcinoma of the Lung,” Chest, Vol. 126, No. 2, 2004, pp. 347-351.
doi:10.1378/chest.126.2.347
|
[24]
|
A. Bryant and R. J. Cerfolio, “Differences in Epidemiology, Histology, and Survival between Cigarette Smokers and Never-Smokers Who Develop Non-Small Cell Lung Cancer,” Chest, Vol. 132, No. 1, 2007, pp. 185-192.
doi:10.1378/chest.07-0442
|